Interference of amino-terminal desmin fragments with desmin filament formation

Cell Motility and the Cytoskeleton

Volumn 66, Issue 11, 2009, Pages 986-999

  Bär, Harald ^a   Sharma, Sarika ^a,b   Kleiner, Helga ^a   Mücke, Norbert ^b   Zentgraf, Hanswalter ^b   Katus, Hugo A ^a   Aebi, Ueli ^c   Herrmann, Harald ^b  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^c UNIVERSITY OF BASEL   (Switzerland)

Author keywords

Analytical ultracentrifugation; Assembly; Desmin; Intermediate filaments; Monoclonal antibody; Premature stop codon

Indexed keywords

DESMIN; VIMENTIN;

AMINO TERMINAL SEQUENCE; CONFERENCE PAPER; CONTROLLED STUDY; CYTOPLASM; FIBROBLAST; HEART MUSCLE CELL; HUMAN; INTERMEDIATE FILAMENT; IONIC STRENGTH; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN ASSEMBLY; PROTEIN DOMAIN; PROTEIN LOCALIZATION;

3T3 CELLS; ADRENOCORTICAL CARCINOMA; ANIMALS; CELL LINE, TRANSFORMED; DESMIN; HEART ATRIA; HUMANS; MICE; MUTANT PROTEINS; MYOCYTES, CARDIAC; PROTEIN INTERACTION DOMAINS AND MOTIFS; PROTEIN MULTIMERIZATION; STRUCTURE-ACTIVITY RELATIONSHIP; VIMENTIN;

EID: 70350212959     PISSN: 08861544     EISSN: 10970169     Source Type: Journal    
DOI: 10.1002/cm.20396     Document Type: Conference Paper

References (37)

1. Amrani N, Sachs MS, Jacobson A. 2006. Early nonsense: mRNA decay solves a translational problem. Nat Rev Mol Cell Biol 7(6):415-425. (Pubitemid 44050095)
2. Arbustini E, Pasotti M, Pilotto A, Pellegrini C, Grasso M, Previtali S, Repetto A, Bellini O, Azan G, Scaffino M, Campana C, Piccolo G, Viganò M, Tavazzi L. 2006. Desmin accumulation restrictive cardiomyopathy and atrioventricular block associated with desmin gene defects. Eur J Heart Fail 8(5):477-483.
3. Bader BL, Magin TM, Freudenmann M, Stumpp S, Franke WW. 1991. Intermediate filaments formed de novo from tail-less cytokeratins in the cytoplasm and in the nucleus. J Cell Biol 115(5):1293-1307. (Pubitemid 21909975)
4. Bär H, Strelkov SV, Sjöberg G, Aebi U, Herrmann H. 2004. The biology of desmin filaments: How do mutations affect their structure, assembly, and organisation? J Struct Biol 148(2):137-152.
5. Bär H, Fischer D, Goudeau B, Kley RA, Clemen CS, Vicart P, Herrmann H, Vorgerd M, Schröder R. 2005a. Pathogenic effects of a novel heterozygous R350P desmin mutation on the assembly of desmin intermediate filaments in vivo and in vitro. Hum Mol Genet 14(10):1251-1260. (Pubitemid 40744485)
6. Bär H, Mücke N, Kostareva A, Sjöberg G, Aebi U, Herrmann H. 2005b. Severe muscle disease-causing desmin mutations interfere with in vitro filament assembly at distinct stages. Proc Natl Acad Sci USA 102(42):15099-15104. (Pubitemid 41513341)
7. Bär H, Kostareva A, Sjöberg G, Sejersen T, Katus HA, Herrmann H. 2006a. Forced expression of desmin and desmin mutants in cultured cells: Impact of myopathic missense mutations in the central coiled-coil domain on network formation. Exp Cell Res 312(9):1554-1565.
8. Bär H, Mücke N, Ringler P, Müller SA, Kreplak L, Katus HA, Aebi U, Herrmann H. 2006b. Impact of disease mutations on the desmin filament assembly process. J Mol Biol 360(5):1031-1042. (Pubitemid 44062518)
9. Bär H, Goudeau B, Wälde S, Casteras-Simon M, Mücke N, Shatunov A, Goldberg YP, Clarke C, Holton JL, Eymard B, Katus HA, Fardeau M, Goldfarb L, Vicart P, Herrmann H. 2007. Conspicuous involvement of desmin tail mutations in diverse cardiac and skeletal myopathies. Hum Mutat 28(4):374-386. (Pubitemid 46542924)
10. Capetanaki Y, Bloch RJ, Kouloumenta A, Mavroidis M, Psarras S. 2007. Muscle intermediate filaments and their links to membranes and membranous organelles. Exp Cell Res 313(10):2063-2076. (Pubitemid 46842980)
11. Chen F, Chang R, Trivedi M, Capetanaki Y, Cryns VL. 2003. Caspase proteolysis of desmin produces a dominant-negative inhibitor of intermediate filaments and promotes apoptosis. J Biol Chem 278(9):6848-6853. (Pubitemid 36800675)
12. Claycomb WC, Lanson NA, Jr, Stallworth BS, Egeland DB, Delcarpio JB, Bahinski A, Izzo NJ, Jr. 1998. HL-1 cells: A cardiac muscle cell line that contracts and retains phenotypic characteristics of the adult cardiomyocyte. Proc Natl Acad Sci USA 95(6):2979-2984.
13. Franke WW, Schmid E, Osborn M, Weber K. 1978. Different intermediate- sized filaments distinguished by immunofluorescence microscopy. Proc Natl Acad Sci USA 75(10):5034-5038. (Pubitemid 9056332)
14. Fuchs E, Cleveland DW. 1998. A structural scaffolding of intermediate filaments in health and disease. Science 279(5350):514-519. (Pubitemid 28067272)
15. Goldfarb LG, Park KY, Cervenakova L, Gorokhova S, Lee HS, Vasconcelos O, Nagle JW, Semino-Mora C, Sivakumar K, Dalakas MC. 1998. Missense mutations in desmin associated with familial cardiac and skeletal myopathy. Nat Genet 19(4):402-403. (Pubitemid 28357917)
16. Goldfarb LG, Vicart P, Goebel HH, Dalakas MC. 2004. Desmin myopathy. Brain 127 (Part 4):723-734.
17. Goldman RD, Milsted A, Schloss JA, Starger J, Yerna MJ. 1979. Cytoplasmic fibers in mammalian cells: Cytoskeletal and contractile elements. Annu Rev Physiol 41:703-722.
18. Haubold K, Herrmann H, Langer SJ, Evans RM, Leinwand LA, Klymkowsky MW. 2003. Acute effects of desmin mutations on cytoskeletal and cellular integrity in cardiac myocytes. Cell Motil Cytoskeleton 54(2):105-121. (Pubitemid 36158157)
19. Hedberg KK, Chen LB. 1986. Absence of intermediate filaments in a human adrenal cortex carcinoma-derived cell line. Exp Cell Res 163(2):509-517.
20. Herrmann H, Aebi U. 1998. Structure, assembly, and dynamics of intermediate filaments. Subcell Biochem 31:319-362.
21. Herrmann H, Aebi U. 2004. Intermediate filaments: Molecular structure, assembly mechanism, and integration into functionally distinct intracellular scaffolds. Annu Rev Biochem 73:749-789. (Pubitemid 39050385)
22. Herrmann H, Eckelt A, Brettel M, Grund C, Franke WW. 1993. Temperature- sensitive intermediate filament assembly. Alternative structures of Xenopus laevis vimentin in vitro and in vivo. J Mol Biol 234(1):99-113. (Pubitemid 23337967)
23. Herrmann H, Haner M, Brettel M, Müller SA, Goldie KN, Fedtke B, Lustig A, Franke WW, Aebi U. 1996. Structure and assembly properties of the intermediate filament protein vimentin: The role of its head, rod and tail domains. J Mol Biol 264(5):933-953. (Pubitemid 27019484)
24. Herrmann H, Haner M, Brettel M, Ku NO, Aebi U. 1999. Characterization of distinct early assembly units of different intermediate filament proteins. J Mol Biol 286(5):1403-1420. (Pubitemid 29121725)
25. Herrmann H, Bär H, Kreplak L, Strelkov SV, Aebi U. 2007. Intermediate filaments: From cell architecture to nanomechanics. Nat Rev Mol Cell Biol 8(7):562-573. (Pubitemid 46985377)
26. Hess JF, Budamagunta MS, Shipman RL, FitzGerald PG, Voss JC. 2006. Characterization of the linker 2 region in human vimentin using site-directed spin labeling and electron paramagnetic resonance. Biochemistry 45(39):11737-11743.
27. Köhler G, Milstein C. 1975. Continuous cultures of fused cells secreting antibody of predefined specificity. Nature 256(5517):495-497.
28. Lazarides E. 1982. Intermediate filaments: A chemically heterogeneous, developmentally regulated class of proteins. Annu Rev Biochem 51:219-250.
29. Mücke N, Wedig T, Burer A, Marekov LN, Steinert PM, Langowski J, Aebi U, Herrmann H. 2004. Molecular and biophysical characterization of assembly-starter units of human vimentin. J Mol Biol 340(1):97-114. (Pubitemid 38739440)
30. Munoz-Marmol AM, Strasser G, Isamat M, Coulombe PA, Yang Y, Roca X, Vela E, Mate JL, Coll J, Fernandez-Figueras MT, Navas-Palacios JJ, Ariza A, Fuchs E. 1998. A dysfunctional desmin mutation in a patient with severe generalized myopathy. Proc Natl Acad Sci USA 95(19):11312-11317.
31. Niehrs C, Huttner WB, Ruther U. 1992. In vivo expression and stoichiometric sulfation of the artificial protein sulfophilin, a polymer of tyrosine sulfation sites. J Biol Chem 267(22):15938-15942.
32. Ohara O, Gahara Y, Miyake T, Teraoka H, Kitamura T. 1993. Neuro- filament deficiency in quail caused by nonsense mutation in neurofilament-L gene. J Cell Biol 121(2):387-395. (Pubitemid 23110882)
33. Paulin D, Huet A, Khanamyrian L, Xue Z. 2004. Desminopathies in muscle disease. J Pathol 204(4):418-427.
34. Sarria AJ, Lieber JG, Nordeen SK, Evans RM. 1994. The presence or absence of a vimentin-type intermediate filament network affects the shape of the nucleus in human SW-13 cells. J Cell Sci 107 (Part 6):1593-1607.
35. Schröder R, Goudeau B, Simon MC, Fischer D, Eggermann T, Clemen CS, Li Z, Reimann J, Xue Z, Rudnik-Schöneborn S, Zerres K, van der Ven PF, Fürst DO, Kunz WS, Vicart P. 2003. On noxious desmin: Functional effects of a novel heterozygous desmin insertion mutation on the extrasarcomeric desmin cytoskeleton and mitochondria. Hum Mol Genet 12(6):657-669. (Pubitemid 36372492)
36. Schröder R, Goudeau B, Casteras-Simon M, Fischer D, Eggermann T, Clemen CS, Li Z, Reimann J, Xue Z, Rudnik-Schöneborn S, Zerres K, van der Ven PF, Fürst DO, Kunz WS, Vicart P. 2007. Corrigendum: On noxious desmin: Functional effects of a novel heterozygous desmin insertion mutation on the extrasarcomeric desmin cytoskeleton and mitochondria. Hum Mol Genet 12(21):1-2.
37. Strelkov SV, Herrmann H, Geisler N, Wedig T, Zimbelmann R, Aebi U, Burkhard P. 2002. Conserved segments 1A and 2B of the intermediate filament dimer: Their atomic structures and role in filament assembly. Embo J 21(6):1255-1266. (Pubitemid 34246505)